InfuSystem Holdings (INFU) Acquisitions (2010 - 2021)

InfuSystem Holdings (INFU) reported Acquisitions of $400000.0 for Q4 2021, up 150.0% quarter-over-quarter from $160000.0 in Q3 2021.

InfuSystem Holdings (INFU) Acquisitions (2010 - 2021) Analysis & Trends

InfuSystem Holdings has reported Acquisitions for 5 years, with the latest figure at $400000.0 in Q4 2021.

For the quarter ending Q4 2021, Acquisitions changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Sep 2022 stood at $400000.0 (down 94.77% YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
Acquisitions for Q4 2021 stood at $400000.0, up from $160000.0 in the prior quarter.
The five-year high for Acquisitions was $6.3 million in Q2 2021, with the low at $160000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-268.10 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.30 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	InfuSystem Holdings	189.78 Mn	187.68 Mn	19.68 Mn	-

Download Data